{{Rsnum
|rsid=9627183
|Chromosome=22
|position=47888765
|Orientation=plus
|GMAF=0.05372
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 8.8 | 91.2
| HCB | 1.5 | 13.9 | 84.7
| JPT | 2.7 | 8.8 | 88.5
| YRI | 0.7 | 19.0 | 80.3
| ASW | 0.0 | 17.5 | 82.5
| CHB | 1.5 | 13.9 | 84.7
| CHD | 0.9 | 14.7 | 84.4
| GIH | 1.0 | 14.9 | 84.2
| LWK | 0.0 | 14.5 | 85.5
| MEX | 0.0 | 5.2 | 94.8
| MKK | 1.3 | 14.1 | 84.6
| TSI | 0.0 | 8.8 | 91.2
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=18821564
|Trait=Attention-deficit/hyperactivity disorder
|Title=Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder
|RiskAllele=C
|Pval=0.0000030000000000000001
|OR=NR
|ORtxt=NR
}}

Associated with [[Attention deficit hyperactivity disorder]].

{{PharmGKB
|RSID=rs9627183
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:18821564; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder. (Initial Sample Size: 187 children; Replication Sample Size: NR); (Region: 22q13.31; Reported Gene: Intergenic; Risk Allele: rs9627183-C) This variant is associated with Attention-deficit/hyperactivity disorder.
|Drugs=
|Drug Classes=
|Diseases=Attention Deficit Disorder with Hyperactivity
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740889
}}

{{PharmGKB
|RSID=rs9627183
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:18821564; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder. (Initial Sample Size: 187 children; Replication Sample Size: NR); (Region: 22q13.31; Reported Gene(s): Intergenic; Risk Allele: rs9627183-C); (p-value= 0.000003).This variant is associated with Attention-deficit/hyperactivity disorder.
|Drugs=
|Drug Classes=
|Diseases=Attention Deficit Disorder with Hyperactivity
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740850
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs9627183
|overall_frequency_n=4
|overall_frequency_d=126
|overall_frequency=0.031746
|n_genomes=4
|n_genomes_annotated=0
|n_haplomes=4
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}